Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
07.11.23
/
50%
€357.80
Target price
07.11.24
€388.11
Performance (%)
30.65%
End price
08.11.24
€467.45
Summary
This prediction ended on 08.11.24 with a price of €467.45. The BUY prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc. saw massive gains of 30.65%. BMO_Capital_Markets has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.845% | 0.845% | -16.396% |
| iShares Core DAX® | 1.659% | 1.586% | 18.113% |
| iShares Nasdaq 100 | 0.381% | 1.900% | 8.877% |
| iShares Nikkei 225® | 2.102% | -1.377% | 13.281% |
| iShares S&P 500 | 0.221% | 1.258% | 3.556% |
Comments by BMO_Capital_Markets for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $389.00 to $415.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.90
20.12.24
20.12.24
€498.52
20.12.25
20.12.25
-2.21%
08:00
08:00
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€349.95
05.08.25
05.08.25
€458.50
05.08.26
05.08.26
7.02%
08:00
08:00
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.40
31.05.24
31.05.24
€459.80
31.05.25
31.05.25
-6.79%
01.06.25
01.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.35
02.08.23
02.08.23
€355.55
02.08.24
02.08.24
35.94%
03.08.24
03.08.24

